Drug Shortage Report for ACTEMRA

Last updated on 2022-06-23 History
Report ID 144365
Drug Identification Number 02350092
Brand name ACTEMRA
Common or Proper name ACTEMRA
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) TOCILIZUMAB
Strength(s) 80MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 80MG/4ML 1VIAL IV
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-07-15
Actual start date
Estimated end date 2022-07-30
Actual end date 2022-06-23
Shortage status Avoided shortage
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2022-06-23 French Compare
v33 2022-06-23 English Compare
v32 2022-06-16 French Compare
v31 2022-06-16 English Compare
v30 2022-06-15 French Compare
v29 2022-06-15 English Compare
v28 2022-04-12 French Compare
v27 2022-04-12 English Compare
v26 2022-04-12 French Compare
v25 2022-04-12 English Compare
v24 2022-04-12 English Compare
v23 2022-03-31 French Compare
v22 2022-03-31 English Compare
v21 2022-03-04 French Compare
v20 2022-03-04 English Compare
v19 2022-03-04 English Compare
v18 2022-02-11 French Compare
v17 2022-02-11 English Compare
v16 2022-01-14 English Compare
v15 2022-01-13 French Compare

Showing 1 to 20 of 34